ImmunoPrecise AntibodiesIPA 
$0.6613.99%24h
13.99%24h
Global rank30690
Market cap$16.43M
Change 7d13.79%
YTD Performance-59.51%
SP500 benchmarkUnderperform
P/E-0.62
P/S1.08
Revenue$15.18M
Earnings-$19.51M
Dividend yield-
ImmunoPrecise Antibodies IPA Operating Margins
Operating Margin in 2022: -1.37%
According to ImmunoPrecise Antibodies latest financial reports the company has an operating margin of -1.37%, an increase of 58.59% to 2022. At the end of 2022 company had an operating margin of -0.86%.
ImmunoPrecise Antibodies Operating Margin from 2020 to 2024
-
Value:-
IPA Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -1.37% | 58.59% |
| 2022 | -0.86% | 269.32% |
| 2021 | -0.23% | -14.34% |
| 2020 | -0.27% | - |
View the highest operating margin companies 
